Steven Gillis, 10% Owner at Prime Medicine, Inc. (PRME), bought 3,030,300 shares at $3.30 ($10.0M) on 2025-08-01, disclosed to the SEC on 2025-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| VBIV | BUY | 2023-07-18 | $2.0M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |
| VBIV | BUY | 2019-09-23 | $5.0M | — | Filing → |